Nashik : In a moving testament to courage and advanced medical care, HCG Manavata Cancer Centre (HCGMCC) successfully treated 15 year old Shweta, a resident the city, a young girl diagnosed with papillary thyroid cancer just as she was preparing for her 10th board examinations. A slight swelling near the throat, noticed by her mother, led to a life changing diagnosis and ultimately a story of healing, hope and resilience. Shweta’s family initially attributed the swelling to exam stress or hormonal changes. But after her exams concluded, a medical consultation revealed a lump in her thyroid gland. Understandably shaken, the family approached HCGMCC, where further investigations including MRI and FNAC confirmed the diagnosis of papillary thyroid cancer (PTC).
PTC accounts for approximately 80 to 85 per cent of all thyroid malignancies and most commonly originates from follicular cells. Known for its slow growing nature, PTC is highly treatable and carries an excellent prognosis. The condition often presents as a painless lump or swelling in the neck and in children, though uncommon, is among the most treatable cancers when detected early and managed appropriately.
“Cancer in a child is emotionally overwhelming for any family. However, thyroid cancers, particularly PTC, have excellent outcomes when diagnosed early and treated promptly. It was important for us not only to treat the disease, but also to reassure the family that Shweta could return to living a completely normal and fulfilling life,” says Prof Dr Raj Nagarkar, Chief of Surgical Oncology & Robotic Services and Managing Director – KIMS Manavata Hospitals, HCG Manavata Cancer Centre and Six Sigma, Nashik.
With renewed confidence, Shweta’s family agreed to proceed with surgery. She was admitted the very next day, underwent successful thyroid surgery, and was discharged within just three days. A crucial part of Shweta’s treatment is radioactive iodine therapy, a post‑surgical procedure that eliminates any microscopic remaining cancer cells. The therapy available in North Maharashtra only at HCGMCC, involves a single, simple dose, followed by routine follow‑up evaluations to ensure complete remission.
“Every cancer journey carries fear and uncertainty, especially when the patient is so young. But stories like Shweta’s remind us that cancer does not mean the end of dreams. With timely intervention, advanced treatment and emotional resilience, patients can emerge stronger and inspire countless others facing similar battles. Moreover, even seemingly minor symptoms such as unexplained swelling should not be ignored, particularly if they persist. Awareness and timely medical evaluation play a critical role in improving outcomes in both paediatric and adolescent cancers,” concludes Dr Nagarkar.
